TerrenceWilliamNorchiMDMBA
Internal Medicine • Framingham, MAPresident and CEO, Arch Therapeutics, Inc.
Dr. Norchi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
235 Walnut St Ste 6
Framingham, MA 01702Phone+1 617-431-2313
Education & Training
MIT SLOAN SCHOOL OF MANAGEMENTMBA, Entrepreneurship and Management, 1994 - 1996
UMass Chan - BaystateChief Residency, Internal Medicine, 1993 - 1994- UMass Chan - BaystateResidency, Internal Medicine, 1990 - 1993
Northeast Ohio Medical UniversityClass of 1990
Certifications & Licensure
MA State Medical License 1991 - 2025
CT State Medical License 2000 - 2012
NY State Medical License 1997 - 2011
NC State Medical License 1992 - 1999
Publications & Presentations
PubMed
- 5 citationsFirst Safety and Performance Evaluation of T45K, a Self-Assembling Peptide Barrier Hemostatic Device, After Skin Lesion Excision.George Rahmani, Jayne Prats, Terrence Norchi, Steven A. Kates, Veronica McInerney
Dermatologic Surgery. 2018-07-01
Press Mentions
Arch Therapeutics : Ladenburg Thalmann 2021 Healthcare Conference PresentationJuly 13th, 2021- Arch Therapeutics’ AC5 Advanced Wound System Presented at the 2020 Symposium on Advanced Wound Care (SAWC) FallNovember 9th, 2020
- Arch Therapeutics Novel Self-Assembling Agent, AC5-GTM, for Use in Endoscopic Procedures Was Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual MeetingAugust 11th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
